secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2022-05-20T23:59:59+00:00
Accession:  0000950170-22-010416
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Palisade Bio receives Nasdaq bid price deficiency notice; 180 days to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notified on May 20, 2022 that PALI common stock closed below $1.00 minimum for 30 consecutive trading days.
- Company has 180 calendar days to regain compliance; stock continues trading under symbol PALI.
- Compliance achieved if closing bid price is $1.00 or more for at least 10 consecutive business days.
- If deficient at end of period, additional 180 days may be available if other listing standards are met.
- Company will monitor bid price and may consider options to cure deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000095017022010416/0000950170-22-010416-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000095017022010416/pali-20220520.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-010416

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer